-
-
-
L287756-100mgPotent SMYD2 inhibitor.
-
L287756-10mgPotent SMYD2 inhibitor.
-
L287756-25mgPotent SMYD2 inhibitor.
-
L287756-50mgPotent SMYD2 inhibitor.
-
L287756-5mgPotent SMYD2 inhibitor.
-
L422185-1mlPotent SMYD2 inhibitor.
-
L414243-100mgInformationLLY-283 LLY-283 is a novel and selective inhibitor of protein arginine methyltransferase 5 (PRMT5) . LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 nM and 25 nM, respectively. LLY-283 shows antitumor
-
L414243-10mgInformationLLY-283 LLY-283 is a novel and selective inhibitor of protein arginine methyltransferase 5 (PRMT5) . LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 nM and 25 nM, respectively. LLY-283 shows antitumor
-
L414243-25mgInformationLLY-283 LLY-283 is a novel and selective inhibitor of protein arginine methyltransferase 5 (PRMT5) . LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 nM and 25 nM, respectively. LLY-283 shows antitumor
-
L414243-50mgInformationLLY-283 LLY-283 is a novel and selective inhibitor of protein arginine methyltransferase 5 (PRMT5) . LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 nM and 25 nM, respectively. LLY-283 shows antitumor